Cargando…

Saquinavir plus methylprednisolone ameliorates experimental acute lung injury

Glucocorticoid insensitivity is an important barrier to the treatment of several inflammatory diseases, including acute lung injury (ALI). Saquinavir (SQV) is an inhibitor of the human immunodeficiency virus protease, and the therapeutic effects of SQV in ALI accompanied with glucocorticoid insensit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guanghua, Zhang, Xue, Huang, Haidi, Ji, Yunxia, Li, Defang, Jiang, Wanglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086550/ https://www.ncbi.nlm.nih.gov/pubmed/30088541 http://dx.doi.org/10.1590/1414-431X20187579

Ejemplares similares

Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo
por: Zhang, Xue, et al.
Publicado: (2019)

Paritaprevir ameliorates experimental acute lung injury in vitro and in vivo
por: Ren, Rui, et al.
Publicado: (2023)

Histopathological effects of lidocain and methylprednisolone in experimental acute lung injury
por: Dogan, N, et al.
Publicado: (2003)

Melatonin Synergizes With Methylprednisolone to Ameliorate Acute Spinal Cord Injury
por: Bi, Jiaqi, et al.
Publicado: (2022)

The protective role of raltegravir in experimental acute lung injury in vitro and in vivo
por: Xu, Zehui, et al.
Publicado: (2022)

New-Onset Saquinavir-Induced Diabetes
por: van Zoelen, Marieke A.D., et al.
Publicado: (2013)

Recombinant human erythropoietin plus methylprednisolone versus methylprednisolone in treatment of acute spinal cord injury：protocol for a systematic review and meta-analysis
por: Fang, Miao, et al.
Publicado: (2022)

Saquinavir Ameliorates Liver Warm Ischemia-Reperfusion-Induced Lung Injury via HMGB-1- and P38/JNK-Mediated TLR-4-Dependent Signaling Pathways
por: Yu, Zhuang, et al.
Publicado: (2017)

Tratamiento con saquinavir + zalcitabina + zidovudina vs saquinavir + lamivudina + zidovudina en pacientes con SIDA sin tratamiento previo
por: Jaimes Martínez, Marcos
Publicado: (2000)

The HIV protease inhibitor Saquinavir attenuates sepsis-induced acute lung injury and promotes M2 macrophage polarization via targeting matrix metalloproteinase-9
por: Tong, Yao, et al.
Publicado: (2021)

Saquinavir: From HIV to COVID-19 and Cancer Treatment
por: Pereira, Mariana, et al.
Publicado: (2022)

Repurposing Alone and in Combination of the Antiviral Saquinavir with 5-Fluorouracil in Prostate and Lung Cancer Cells
por: Pereira, Mariana, et al.
Publicado: (2022)

Unexpected Hepatotoxicity of Rifampin and Saquinavir/Ritonavir in Healthy Male Volunteers
por: Schmitt, Christophe, et al.
Publicado: (2009)

Potential Hepatotoxicity of Efavirenz and Saquinavir/Ritonavir Coadministration in Healthy Volunteers
por: Jamois, Candice, et al.
Publicado: (2009)

A Case of Nephrotic Syndrome, Showing Evidence of Response to Saquinavir
por: Walters, Giles, et al.
Publicado: (2015)

Saquinavir-Piperine Eutectic Mixture: Preparation, Characterization, and Dissolution Profile
por: Fandaruff, Cinira, et al.
Publicado: (2023)

Study on the Efficacy and Safety of Ambroxol Combined with Methylprednisolone in Patients with Acute Lung Injury
por: Su, Weiwei, et al.
Publicado: (2021)

Treatment of postoperative lung injury in patients with SIRS by methylprednisolone
por: Sumida, M, et al.
Publicado: (1998)

Protective effects of ulinastatin and methylprednisolone against radiation-induced lung injury in mice
por: Sun, Yu, et al.
Publicado: (2016)

Enhancement of saquinavir absorption and accumulation through the formation of solid drug nanoparticles
por: Kigen, Gabriel, et al.
Publicado: (2018)

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Methylprednisolone inhibits Nogo-A protein expression after acute spinal cord injury
por: Fu, Zhaozong, et al.
Publicado: (2013)

Methylprednisolone/prednisolone: Prolongation of the lung injury healing: case report
Publicado: (2022)

Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis
por: Tommasi, Chiara, et al.
Publicado: (2011)

Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4(+) immune cells
por: Yang, Sidi, et al.
Publicado: (2013)

Microglial activation decreases retention of the protease inhibitor saquinavir: implications for HIV treatment
por: Dallas, Shannon, et al.
Publicado: (2013)

Methylprednisolone for acute spinal cord injury: an increasingly philosophical debate
por: Bowers, Christian A., et al.
Publicado: (2016)

Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure
por: Giraldo-Velásquez, Manuel F., et al.
Publicado: (2022)

The Potential Therapeutic Effects of Agmatine, Methylprednisolone, and Rapamycin on Experimental Spinal Cord Injury
por: Firat, Tulin, et al.
Publicado: (2021)

Safety and Efficacy in HIV-1-Infected Patients Treated with Ritonavir-Boosted Saquinavir Mesylate
por: Knechten, Heribert, et al.
Publicado: (2010)

Combined treatment with bone marrow mesenchymal stem cells and methylprednisolone in paraquat-induced acute lung injury
por: Yang, Huang, et al.
Publicado: (2013)

Paraquat induced acute kidney and lung injury with a dramatic response to methylprednisolone: A case report
por: Asaduzzaman, Md, et al.
Publicado: (2023)

Granulocyte Colony-Stimulating Factor Combined with Methylprednisolone Improves Functional Outcomes in Rats with Experimental Acute Spinal Cord Injury
por: Teixeira, William Gemio Jacobsen, et al.
Publicado: (2018)

Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury
por: Li, Nan, et al.
Publicado: (2017)

Effects of acute and chronic administration of methylprednisolone on oxidative stress in rat lungs
por: Torres, Ronaldo Lopes, et al.
Publicado: (2014)

Effects of resveratrol on P-glycoprotein and cytochrome P450 3A in vitro and on pharmacokinetics of oral saquinavir in rats
por: Li, Jiapeng, et al.
Publicado: (2016)

Evaluation of novel Saquinavir analogs for resistance mutation compatibility and potential as an HIV-Protease inhibitor drug
por: Jayaswal, Amit, et al.
Publicado: (2014)

Synthesis of biogenic gold nano conjugate for increased efficacy and sustained drug release profile of saquinavir
por: Kesarkar, Rohan, et al.
Publicado: (2014)

The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines
por: Bandiera, Elisabetta, et al.
Publicado: (2016)

Enhanced intestinal lymphatic absorption of saquinavir through supersaturated self-microemulsifying drug delivery systems
por: Jo, Kanghee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b370fl26djlumd8db6fs418gla